These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 476707)
1. Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapy. Falkson HC; van der Watt JJ; Portugal MA; Schoeman HS; Falkson G Cancer Treat Rep; 1979 Aug; 63(8):1303-9. PubMed ID: 476707 [TBL] [Abstract][Full Text] [Related]
2. Leukocyte alkaline phosphatase and carcinoembryonic antigen in breast cancer patients. Influence of the treatment on the markers. Walach N; Guterman A; Zaidman JL; Scharf S; Weinberger L; Kaufman S Neoplasma; 1990; 37(6):627-30. PubMed ID: 2274082 [TBL] [Abstract][Full Text] [Related]
3. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer. Lamerz R; Leonhardt A; Ehrhart H; von Lieven H Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699 [TBL] [Abstract][Full Text] [Related]
4. Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer. Tondini C; Hayes DF; Gelman R; Henderson IC; Kufe DW Cancer Res; 1988 Jul; 48(14):4107-12. PubMed ID: 3164256 [TBL] [Abstract][Full Text] [Related]
5. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer]. Krieger G; Wander HE; Prangen M; Bandlow G; Beyer JH; Nagel GA Dtsch Med Wochenschr; 1983 Apr; 108(16):610-4. PubMed ID: 6839982 [TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapy. Falkson HC; Falkson G; Portugal MA; van der Watt JJ; Schoeman HS Cancer; 1982 May; 49(9):1859-65. PubMed ID: 7074585 [TBL] [Abstract][Full Text] [Related]
7. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)]. Pompecki R; Schröder G; Garbrecht M; Frahm H Dtsch Med Wochenschr; 1978 Apr; 103(14):620-2. PubMed ID: 639696 [TBL] [Abstract][Full Text] [Related]
8. Serial CEA determinations as an aid in postoperative therapy management of patients with early breast cancer. Ahlemann LM; Staab HJ; Anderer FA Biomedicine; 1980 Dec; 32(4):194-9. PubMed ID: 7470582 [TBL] [Abstract][Full Text] [Related]
9. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer. Staab HJ; Ahlemann LM; Koch HL; Anderer FA Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702 [TBL] [Abstract][Full Text] [Related]
10. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer]. Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108 [TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer. Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319 [TBL] [Abstract][Full Text] [Related]
12. Three-year follow-up of carcinoembryonal antigen levels in the serum of patients with breast cancer. Lang BA; Kocent A; Nekulová M; Hlávková J Neoplasma; 1984; 31(1):79-87. PubMed ID: 6700798 [TBL] [Abstract][Full Text] [Related]
13. Postoperative borderline elevated CEA predicts for earlier relapse in patients with rectal cancer receiving adjuvant postoperative therapy. Dawson LA; Franssen E; Davey P Cancer J Sci Am; 1999; 5(6):374-9. PubMed ID: 10606480 [TBL] [Abstract][Full Text] [Related]
14. Transient carcinoembryonic antigen elevations during adjuvant chemotherapy for colorectal cancer reflect the burden of residual micrometastatic disease. Yau T; Wong H; Chan P; Chan T; Mak J; Epstein RJ Clin Colorectal Cancer; 2010 Apr; 9(2):108-12. PubMed ID: 20378505 [TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse. Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194 [TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen (CEA) measurements as an aid to management of patients with lung cancer treated by radiotherapy. Ahlemann LM; Staab HJ; Koch HL; Anderer FA Oncodev Biol Med; 1980; 1(3):143-50. PubMed ID: 7279701 [TBL] [Abstract][Full Text] [Related]
17. Correlation of single and serial CEA determinations with the clinical evolution of cancer patients. de Levin RW; Levin E Arch Geschwulstforsch; 1982; 52(2):105-12. PubMed ID: 7103688 [TBL] [Abstract][Full Text] [Related]
18. A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal study. Guadagni F; Ferroni P; Carlini S; Mariotti S; Spila A; Aloe S; D'Alessandro R; Carone MD; Cicchetti A; Ricciotti A; Venturo I; Perri P; Di Filippo F; Cognetti F; Botti C; Roselli M Clin Cancer Res; 2001 Aug; 7(8):2357-62. PubMed ID: 11489813 [TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen in patients with colorectal cancer: correlation between stage of disease and antigen level. Bartal AH; Ayalon D; Cordova T; Avidan S; Robinson E Isr J Med Sci; 1983 Sep; 19(9):801-5. PubMed ID: 6643017 [TBL] [Abstract][Full Text] [Related]
20. Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer. Mughal AW; Hortobagyi GN; Fritsche HA; Buzdar AU; Yap HY; Blumenschein GR JAMA; 1983 Apr; 249(14):1881-6. PubMed ID: 6834584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]